Novavax shares jumped 50% on Monday following its recent licensing deal with Sanofi, as meme stocks are making a 2021-style ...
opens new tab on Friday said it had struck a licensing deal worth ... well as royalties. Sanofi, one of the world's largest vaccine makers, will gain a license to co-sell Novavax's vaccine in ...
The biotech company said it would develop a combination Covid and flu shot with Sanofi as part of a billion-dollar deal.
Novavax (NVAX) shares are skyrocketing after the company announced a $1.2 billion deal with French drugmaker Sanofi (SNY). B.
Novavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined COVID-19 and ...
Novavax said the licensing agreement allows ... will co-market Novavax's Covid vaccine in most countries starting in 2025. The deal also allows Sanofi to use Novavax's Covid shot and flagship ...
French pharma major Sanofi (Euronext: SAN) says that, as part of its commitment to developing a diverse portfolio of best-in-class vaccines, it has entered into a co-exclusive licensing agreement with ...
erased doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with Sanofi, for Covid-19 vaccines in exchange for a stake that doubles the US drugmaker's ...
Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm at ...
Novavax (NASDAQ:NVAX) shares hit a 52-week high on Friday as the COVID-19 vaccine maker removed its going-concern notice with its Q1 2024 financials on the back of a licensing deal with Sanofi ...